Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’

Craig Crews has in­cu­bat­ed some no­table biotech com­pa­nies this cen­tu­ry, and hun­dreds of thou­sands of blood can­cer pa­tients have ben­e­fit­ed from a med­i­cine with roots …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.